Development of a dedicated phantom for multi‐target single‐isocentre stereotactic radiosurgery end to end testing. (16th September 2018)

• Record Type: Journal Article
• Authors: Poder, Joel; Brown, Ryan; Porter, Harry; Gupta, Rashmi; Ralston, Anna
• Is Part Of: Journal of applied clinical medical physics. Volume 19:Number 6(2018)
• Page Start: 99
• Page End: 108
• Publication Date: 2018-09-16
• Subjects: dosimetric validation -- end‐to‐end testing -- MRI deformation -- multi‐target -- single isocentre -- stereotactic radiosurgery; Medical physics -- Periodicals; Clinical medicine -- Periodicals; Health Physics; Clinical Medicine; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; 610.153
• DOI: 10.1002/acm2.12452
• Languages: English
• ISSNs: 1526-9914

Abstract

Abstract: Purpose: The aim of this project was to design and manufacture a cost‐effective end‐to‐end (E2E) phantom for quantifying the geometric and dosimetric accuracy of a linear accelerator based, multi‐target single‐isocenter (MTSI) frameless stereotactic radiosurgery (SRS) technique. Method: A perspex Multi‐Plug device from a Sun Nuclear ArcCheck phantom (Sun Nuclear, Melbourne, FL) was enhanced to make it more applicable for MTSI SRS E2E testing. The following steps in the SRS chain were then analysed using the phantom: magnetic resonance imaging (MRI) distortion, planning computed tomography (CT) scan and MRI image registration accuracy, phantom setup accuracy using CBCT, dosimetric accuracy using ion chamber, planar film dose measurements and coincidence of linear accelerator mega‐voltage (MV), and kilo‐voltage (kV) isocenters using Winston‐Lutz testing (WLT). Results: The dedicated E2E phantom was able to successfully quantify the geometric and dosimetric accuracy of the MTSI SRS technique. MRI distortions were less than 0.5 mm, or half a voxel size. The average MRI‐CT registration accuracy was 0.15 mm (±0.31 mm), 0.20 mm (±0.16 mm), and 0.39 mm (±0.11 mm) in the superior/inferior, left/right and, anterior/posterior directions, respectively. The phantom setup accuracy using CBCT was better than 0.2 mm and 0.1°. Point dose measurements were within 5% of the treatment planning system predicted dose. The comparison of planar film doses to the planning system dose distributions, performed using gamma analysis, resulted in pass rates greater than 97% for 3%/1 mm gamma criteria. Finally, off‐axis WLT showed MV/kV coincidence to be within 1 mm for off‐axis distances up to 60 mm. Conclusion: A novel, versatile and cost‐effective phantom for comprehensive E2E testing of MTSI SRS treatments was developed, incorporating multiple detector types and fiducial markers. The phantom is capable of quantifying the accuracy of each step in the MTSI SRS planning and treatment process.